For personal use only
Appendix 3Y
Change of Director's Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Rhythm Biosciences Limited
ABN | 59 619 459 335 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Otto Buttula |
Date of last notice | 9 September 2021 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Indirect | |
Nature of indirect interest | 1) | Newfound Investments Pty Ltd |
(including registered holder) | ||
Note: Provide details of the circumstances giving rise to the relevant | ||
interest. | ||
2) | Webinvest Pty Ltd | |
Date of change | 25 November 2021 | |
- See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director's Interest Notice
No. of securities held prior to change | 1) | Newfound Investments Pty Ltd | ||
only | 2) | 11,001,667 fully paid ordinary shares | ||
Webinvest Pty Ltd | ||||
(ASX: RHY) | ||||
134,167 Unlisted options | ||||
(ASX: RHYAK) expiring 31 August 2022 | ||||
134,167 Unlisted options | ||||
(ASX: RHYAL) expiring 31 July 2024 | ||||
use | ||||
17,083,334 fully ordinary paid shares | ||||
(ASX: RHY) | ||||
208,334 Unlisted options | ||||
(ASX: RHYAK) expiring 31 August | ||||
2022 | ||||
208,334 Unlisted options | ||||
personalFor | (ASX: RHYAL) expiring 31 July 2024 | |||
Class | Unlisted options (ASX: RHYAI) expiring | |||
31 July 2024 | ||||
Number acquired | 2,000,000 | |||
Number disposed | Nil | |||
Value/Consideration | Refer to Notice of Meeting lodged with | |||
Note: If consideration is non-cash, provide details and estimated | ASX on 20 October 2021 for further | |||
valuation | information. | |||
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 | 01/01/2011 |
For personal use only
Appendix 3Y | |||
Change of Director's Interest Notice | |||
No. of securities held after change | 1) Newfound Investments Pty Ltd | ||
11,001,667 fully paid ordinary shares | |||
(ASX: RHY) | |||
134,167 Unlisted options | |||
(ASX: RHYAK) expiring 31 August 2022 | |||
134,167 Unlisted options | |||
(ASX: RHYAL) expiring 31 July 2024 | |||
2,000,000 Unlisted options (ASX: | |||
RHYAI) expiring 31 July 2024 | |||
2) Webinvest Pty Ltd | |||
17,083,334 fully ordinary paid shares | |||
(ASX: RHY) | |||
208,334 Unlisted options | |||
(ASX: RHYAK) expiring 31 August | |||
2022 | |||
208,334 Unlisted options | |||
(ASX: RHYAL) expiring 31 July 2024 | |||
Nature of change | 2,000,000 unlisted options issued via | ||
Example: on-market trade, off-market trade, exercise of options, | shareholder approval received on 24 | ||
issue of securities under dividend reinvestment plan, participation in | November 2021 - | ||
buy-back | |||
refer to Notice of Meeting lodged with | |||
ASX on 20 October 2021. |
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract | n/a |
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change
Note: Details are only required for a contract in relation to which the interest has changed
- See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3
For personal use only
Appendix 3Y
Change of Director's Interest Notice
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change
Part 3 - +Closed period
Were the interests in the securities or contracts detailed n/a above traded during a +closed period where prior written clearance was required?
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?
+ See chapter 19 for defined terms.
Appendix 3Y Page 4 | 01/01/2011 |
For personal use only
Appendix 3Y
Change of Director's Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Rhythm Biosciences Limited
ABN | 59 619 459 335 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Lou Panaccio |
Date of last notice | 9 September 2021 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Indirect |
Nature of indirect interest | Tercus Pty Ltd |
(including registered holder) | |
Note: Provide details of the circumstances giving rise to the relevant | |
interest. | |
Date of change | 25 November 2021 |
No. of securities held prior to change | Held by Beneficial interest through |
Tercus Pty Ltd: | |
820,000 fully paid ordinary shares (ASX: | |
RHY) | |
10,000 Unlisted options (ASX: RHYAK) | |
expiring 31 August 2022 | |
10,000 Unlisted options (ASX: RHYAL) | |
expiring 31 July 2024 | |
- See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Rhythm Biosciences Ltd. published this content on 25 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 November 2021 06:49:06 UTC.